| Literature DB >> 32498606 |
Gemma Learmonth1,2, Christopher S Y Benwell2,3, Gesine Märker2, Diana Dascalu2, Matthew Checketts2,4, Celestine Santosh5, Mark Barber6, Matthew Walters7, Keith W Muir1, Monika Harvey2.
Abstract
Up to 80% of people who experience a right-hemisphere stroke suffer from hemispatial neglect. This syndrome is debilitating and impedes rehabilitation. We carried out a clinical feasibility trial of transcranial direct current stimulation (tDCS) and a behavioural rehabilitation programme, alone or in combination, in patients with neglect. Patients >4 weeks post right hemisphere stroke were randomized to 10 sessions of tDCS, 10 sessions of a behavioural intervention, combined intervention, or a control task. Primary outcomes were recruitment and retention rates, with secondary outcomes effect sizes on measures of neglect and quality of life, assessed directly after the interventions, and at 6 months follow up. Of 288 confirmed stroke cases referred (representing 7% of confirmed strokes), we randomized 8% (0.6% of stroke cases overall). The largest number of exclusions (91/288 (34%)) were due to medical comorbidities that prevented patients from undergoing 10 intervention sessions. We recruited 24 patients over 29 months, with 87% completing immediate post-intervention and 67% 6 month evaluations. We established poor feasibility of a clinical trial requiring repeated hospital-based tDCS within a UK hospital healthcare setting, either with or without behavioural training, over a sustained time period. Future trials should consider intensity, duration and location of tDCS neglect interventions.Trial registration: ClinicalTrials.gov identifier: NCT02401724.Entities:
Keywords: Hemispatial neglect; Non-invasive brain stimulation; Prospective randomized open blinded end-point (PROBE) trial; Stroke; Transcranial direct current stimulation (tDCS)
Mesh:
Year: 2020 PMID: 32498606 PMCID: PMC8372288 DOI: 10.1080/09602011.2020.1767161
Source DB: PubMed Journal: Neuropsychol Rehabil ISSN: 0960-2011 Impact factor: 2.928
Examples of tDCS neglect studies listing patient numbers, stimulation type, sessions and type of intervention as well as the main findings.
| Study | N of Patients | Type of Stimulation | Number of Sessions | Main Findings |
|---|---|---|---|---|
| Ko et al. ( | 15 | R Anodal; Sham | Crossover, 1 session each | Line bisection and Figure cancellation improvements |
| Sparing et al. ( | 10 | R Anodal; L Cathodal; L Anodal; Sham | Crossover, 1 session each | Line bisection improvement with R Anodal; L Cathodal |
| Sunwoo et al. ( | 10 | Bilateral R Anodal & L Cathodal; R anodal; Sham | Crossover, 1 session each | Line bisection improvements greatest for combined stimulation |
| Brem et al. ( | 1 | Bilateral R Anodal & L Cathodal; Sham; Cognitive Therapy | Crossover, 5 sessions each, various combinations | Covert attention and qualitative Line bisection and Copying improvements |
| Ladavas et al. ( | 30 | R Anodal; L Cathodal; Sham (combined with prism adaptation) | Between groups, 10 sessions | Greatest BIT improvement for R Anodal |
| Smit et al. ( | 5 | Bilateral R Anodal & L Cathodal; Sham | Crossover, 5 sessions each | No effects |
| Bang and Bong ( | 12 | Bilateral R Anodal & L Cathodal; Control group (with feedback training) | Between groups, 15 sessions | Greatest changes for Line bisection, Perception test |
| Yi et al. ( | 30 | R Anodal; L Cathodal; Sham | Between groups, 15 sessions | Greatest changes for Line bisection, Cancellation for both anodal, cathodal conditions |
| O’Shea et al. ( | 3 | L Anodal with prism adaptation; Sham | Crossover, 4 sessions each, various combinations | Long term gains in neglect scores mainly in cancellation tasks |
| Turgut et al. ( | 32 | Bilateral R Anodal & L Cathodal; Standard treatment control group (with optokinetic training) | Between groups, 8 sessions | Greatest improvement for Clock Drawing, Body orientation |
| Bornheim et al. ( | 4 | R Anodal; Sham | Crossover, 2 sessions each | Star cancellation, line bisection and Catherine Bergego Scale. “During the weeks of real tDCS, improvements were much greater than in the weeks with sham” (no statistics reported). |
| Chieffo et al. ( | 15 | R Anodal, L Cathodal, Sham (with prism adaptation) | Crossover, 1 session each | R anodal reduced leftward pointing shift after prism adaptation. |
Figure 1.Electrode montage and simulated current flow, performed with SimNIBS 3.1.0 (Thielscher et al., 2015). The 5 × 7 cm anode was positioned just anterior to the vertex (Cz) and the 5 × 5 cm cathode positioned over the left parietal cortex (P3). The normalized induced electric field (normE) is shown in V/m and the current induced by each electrode in mA.
Figure 2.Example of the Behavioural Training.
Characteristics of the randomized cohort.
| Intervention | ID | Age | Sex | Neglect severity | Days from stroke to T1 | Days to complete interventions (T2-T1) | Days to follow-up (T3-T2) | Aetiology | Lesion location | Visual field deficit | Inpatient/Outpatient at time of intervention | SAEs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| tDCS | 1 | 78 | M | High | 34 | 23 | Died | I | Right temporo-occipital + thalamus | Y | IP | Unrelated: DVT + PTE, died |
| 2 | 56 | M | High | 495 | 16 | 264 | I | Right PCA (temporo-occipito-parietal + basal ganglia) | Y | IP | – | |
| 3 | 61 | F | Low | 39 | 15 | 179 | I | Right MCA | N | OP | – | |
| 4 | 67 | F | Low | 1394 | 34 | 192 | H | Right fronto-parietal | N | OP | – | |
| 5 | 64 | M | Low | 786 | 66 | 181 | H | Right parietal | N | OP | – | |
| 6 | 70 | F | Low | 68 | 47 | 178 | I | Right MCA | N | OP | – | |
| Behavioural training | 7 | 54 | M | High | 38 | 19 | Lost Contact | I | Right MCA | Not testable | IP | – |
| 8 | 79 | M | High | 74 | 46 | 193 | I | Right PCA | Y | OP | – | |
| 9 | 75 | M | Low | 32 | 42 | 217 | I | Right MCA + temporal | N | OP | – | |
| 10 | 72 | F | Low | 37 | 15 | Died | I | Right fronto-parietal | Y | IP | Unrelated: died | |
| 11 | 59 | F | Low | 2020 | 43 | Lost Contact | H | Right fronto-parietal | N | OP | – | |
| 12 | 62 | M | Low | 55 | Withdrew | Withdrew | H | Right basal ganglia | N/A tested | OP | – | |
| Combined intervention | 13 | 84 | F | High | 36 | Unable | Withdrew | I | Right uncus, hippocampus, internal capsule, pons and cerebellum | Y | IP | – |
| 14 | 73 | F | High | 34 | 60 (6/10 sessions) | Lost Contact | I | Right MCA | Not testable | IP | – | |
| 15 | 65 | M | Low | 45 | 21 | 193 | I | Right fronto-parietal + temporo-occipital + thalamus | Y | OP | Unrelated: new onset seizures | |
| 16 | 62 | M | Low | 1727 | 28 | 192 | I | Right MCA | N | OP | – | |
| 17 | 73 | F | Low | 75 | 51 | 189 | I | Nil new, old right frontal | N | OP | – | |
| 18 | 66 | F | Low | 426 | 44 | Lost Contact | I | Right MCA | N | OP | – | |
| Control training | 19 | 45 | F | High | 38 | 36 | Lost Contact | I | Right MCA | N | IP | – |
| 20 | 60 | M | High | 78 | 11 | 229 | I | Right MCA + internal capsule | Y | IP | Unrelated: PTE | |
| 21 | 76 | M | Low | 39 | 25 | 199 | I | Right MCA | Y | OP | – | |
| 22 | 67 | F | Low | 1859 | Withdrew | Withdrew | I | Right MCA | N/A | OP | – | |
| 23 | 63 | M | Low | 1028 | 29 | 210 | I | Right parietal | N | OP | – | |
| 24 | 52 | M | Low | 458 | 38 | 227 | H | Right fronto-parietal | Y | OP | – | |
Note: Neglect Severity: high = BIT score of <115. Visual Field Deficit: not testable: 2 patients could not be assessed due to their inability to sustain attention sufficiently to complete the test, N/A: 2 patients withdrew before the in-house testing could be performed. Unable: the patient could not tolerate the tDCS montage as experienced severe itching and was unable to carry out behavioural training. T1: time of baseline secondary outcome measure testing, T2: time of post-intervention testing, T3: time of follow-up testing. SAE: Serious Adverse Event. DVT: Deep Vein Thrombosis. PTE: Pulmonary Thromboembolism. IP: inpatient. OP: outpatient.
Figure 3.Number of confirmed (red line), estimated right hemisphere (green line), referred (purple line) and randomized strokes (blue line) presented cumulatively over the recruitment period.
Number of patients referred and randomized out of all patients admitted with confirmed stroke (Scottish Stroke Care Unit (SSCA) records) and out of estimated (estimated at 45% of the total confirmed strokes) right hemisphere strokes.
| Recruitment Site | N of confirmed strokes | N of estimated right hemisphere strokes (estimated at 45% of total confirmed) | N referred to trial | N randomized into trial |
|---|---|---|---|---|
| QEUH | 2038 | 919 | 161 | 19 |
| GRI | 1100 | 495 | 113 | 1 |
| RAH | 678 | 305 | 11 | 2 |
| Lanarkshire | 495 | 223 | 3 | 2 |
Note: Data listed separately for the 4 recruitment sites: QEUH: Queen Elizabeth University Hospital; GRI: Glasgow Royal Infirmary; RAH: Royal Alexandra Hospital.
Figure 4.Consort Flow Diagram. T1: time of baseline secondary outcome measure testing, T2: time of post-intervention testing, T3: time of follow-up testing. LNS: low neglect severity (BIT score of >115). HNS: high neglect severity (BIT score of <115).
Figure 5.Lesion maps for each of the 24 individuals, projected onto 13 axial slices of the standardized older adult MNI template ((scct.nii) developed by Rorden et al., 2012), plus the cumulative overlap map. Orientation is per neuroscience standard with the right hemisphere on the right side in each slice.
Scores for each participant, separated by secondary outcome measures.
| Group | BIT1 | Line bisection2 | Balloons A3 | Balloons B3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | T1 | T2 | T3 | T1 | T2 | T3 | T1 | T2 | T3 | T1 | T2 | T3 | |
| 45 | 58 | – | 7.69 | 5.94 | – | 25.00 | 18.18 | – | – | 100.0 | – | ||
| 56 | 121 | 131 | 0.74 | −1.67 | 0.90 | 0.00 | 45.00 | 50.00 | 0.00 | 61.54 | 43.75 | ||
| 134 | 142 | 144 | −1.01 | −0.43 | −0.01 | 52.63 | 50.00 | 50.00 | 47.06 | 35.71 | 50.00 | ||
| 137 | 140 | 136 | 0.85 | 0.42 | 0.48 | 50.00 | 50.00 | 50.00 | 62.50 | 63.60 | 52.94 | ||
| 138 | 142 | 143 | 0.62 | 0.53 | 0.02 | 50.00 | 47.37 | 50.00 | 50.00 | 56.25 | 50.00 | ||
| 121 | 113 | 127 | −0.31 | −0.73 | −0.37 | 41.18 | 50.00 | 50.00 | 14.29 | 12.50 | 25.00 | ||
| 89 | 122 | – | 3.88 | 2.36 | – | 0.00 | 40.00 | – | 14.29 | 42.86 | – | ||
| 75 | 117 | 104 | 8.56 | 0.65 | 6.77 | 35.71 | 52.63 | 0.00 | 25.00 | 54.55 | 0.00 | ||
| 142 | 145 | 142 | 0.96 | −0.02 | 0.01 | 52.63 | 50.00 | 55.56 | 42.86 | 53.85 | 56.25 | ||
| 117 | 132 | – | 0.66 | 0.29 | – | 50.00 | 50.00 | – | 46.67 | 58.30 | – | ||
| 135 | 136 | – | −0.63 | −0.10 | – | 50.00 | 50.00 | – | 52.90 | 56.25 | – | ||
| 132 | – | – | 0.51 | – | – | 47.37 | – | – | 27.27 | – | – | ||
| 30 | – | – | 8.47 | – | – | 0.00 | – | – | 0.00 | – | – | ||
| 81 | 109 | – | 0.57 | 1.63 | – | 23.08 | 25.00 | – | 0.00 | 0.00 | – | ||
| 123 | 136 | 137 | 0.01 | 0.06 | 0.15 | 52.63 | 50.00 | 50.00 | 50.00 | 50.00 | 70.00 | ||
| 124 | 135 | 137 | 0.27 | −0.20 | −0.44 | 50.00 | 50.00 | 50.00 | 66.67 | 50.00 | 53.33 | ||
| 122 | 125 | 117 | −0.17 | −0.20 | −0.32 | 55.56 | 52.63 | 50.00 | 52.94 | 66.67 | 57.14 | ||
| 138 | 126 | – | −0.15 | −0.69 | – | 50.00 | 50.00 | – | 56.25 | 44.44 | – | ||
| 108 | 124 | – | −0.12 | −0.57 | – | 23.08 | 50.0 | – | 0.00 | 30.00 | – | ||
| 98 | 114 | 126 | −0.76 | 0.36 | 0.30 | 0.00 | 0.00 | 44.44 | 0.00 | 11.11 | 28.57 | ||
| 125 | 137 | 135 | −0.30 | −0.34 | −0.12 | 58.82 | 52.63 | 50.00 | 57.14 | 55.56 | 43.75 | ||
| 134 | – | – | −0.68 | – | – | 52.63 | – | – | 27.27 | – | – | ||
| 142 | 132 | 138 | 0.39 | 0.08 | 0.42 | 50.00 | 50.00 | 50.00 | 47.06 | 50.00 | 52.94 | ||
| 135 | 144 | 141 | 0.18 | −1.08 | −0.55 | 50.00 | 50.00 | 50.00 | 50.00 | 33.30 | 47.06 | ||
Notes: 1. Behavioural Inattention Test (BIT). Positive change scores indicate a reduction of neglect (i.e., higher score in T2 relative to T1). 2. Line bisection. Negative change scores indicate a reduction of neglect (i.e., line bisected further to the left in T2 relative to T1). 3. Balloons (A&B). Positive change scores indicate a reduction of neglect (i.e., higher percentage of cancellations on the left in T2 relative to T1). T1: time of baseline secondary outcome measure testing, T2: time of post-intervention testing, T3: time of follow-up testing.
Scores for each participant, separated by secondary outcome measures.
| Group | BDI6 | SIS ADL/IADL7 | SIS Percentage recovery8 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ID | T1 | T2 | T3 | T1 | T2 | T3 | T1 | T2 | T3 | |
| 10 | 4 | – | 50 | 95.8 | – | 20 | 15 | – | ||
| 3 | 7 | 2 | 90.0 | 70.0 | 100.0 | – | 15 | 70 | ||
| 6 | 3 | 21 | 60.0 | 90.0 | 97.5 | 60 | 80 | 90 | ||
| 3 | 3 | 1 | 75.0 | 80.0 | 90.0 | 80 | 80 | 80 | ||
| 25 | 11 | 9 | 55.0 | 55.0 | 55.0 | 30 | 40 | 40 | ||
| – | – | – | – | – | – | – | – | – | ||
| 30 | 19 | – | 5 | 15 | – | 20 | 40 | – | ||
| 5 | 3 | 1 | 62.5 | 90 | 90 | 50 | 50 | 80 | ||
| 5 | 4 | 3 | 33.3 | 82.5 | 90 | 60 | 80 | 80 | ||
| 8 | 14 | – | 57.5 | 41.7 | – | 45 | 35 | – | ||
| 30 | 28 | – | 35 | 32.5 | – | – | 35 | – | ||
| – | – | – | – | – | – | – | – | – | ||
| – | – | – | – | – | – | – | – | – | ||
| 13 | 19 | – | – | – | – | – | – | |||
| 9 | 8 | 6 | 62.5 | 87.5 | 86.1 | 70 | 80 | 70 | ||
| 27 | 44 | 33 | 35 | 2.5 | 37.5 | 70 | 40 | 70 | ||
| 12 | 6 | – | 85 | 86.1 | 83.3 | 60 | 80 | 60 | ||
| 6 | 4 | – | 97.5 | 97.5 | – | 60 | 60 | – | ||
| 24 | 23 | – | 36.1 | 37.5 | – | 20 | 50 | – | ||
| 3 | 0 | 11 | 82.5 | 92.5 | 70.0 | 75 | 80 | – | ||
| 6 | 5 | 7 | – | – | – | – | – | – | ||
| – | – | – | 47.5 | 44.4 | 58.3 | 60 | 60 | 30 | ||
| 13 | 16 | 34 | – | 86.1 | 2.5 | – | 70 | 40 | ||
| 12 | 9 | 37.5 | 82.5 | – | 70 | 75 | – | |||
Notes: 6. Beck Depression Inventory (BDI). Negative change scores indicate an improvement (i.e., lower score in T2 relative to T1). 7. Stroke Impact Scale (ADL/IADL). Positive change scores indicate an improvement in activities of daily living (i.e., higher score in T2 relative to T1). 8. Stroke Impact Scale (Stroke recovery). Positive change scores indicate an improvement in the patient’s subjective total recovery (i.e., higher score in T2 relative to T1). T1: time of baseline secondary outcome measure testing, T2: time of post-intervention testing, T3: time of follow-up testing.
Scores for each participant, separated by secondary outcome measures.
| Group | Hearts A egocentric4 | Hearts A allocentric5 | Hearts B egocentric4 | Hearts B allocentric5 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | T1 | T2 | T3 | T1 | T1 | T2 | T1 | T1 | T2 | T1 | T1 | T2 | |
| 7 | 2 | – | −2 | 1 | 4 | 3 | 3 | – | 1 | 4 | – | ||
| 17 | 10 | 11 | 0 | 1 | 4 | 9 | 5 | 7 | 1 | 4 | 2 | ||
| 0 | 0 | 4 | 1 | 3 | 2 | 1 | −2 | −2 | 3 | 2 | 0 | ||
| 4 | 3 | −6 | 2 | 4 | −5 | 0 | −3 | 5 | 4 | −5 | −3 | ||
| 1 | 1 | −3 | 2 | −2 | 1 | −4 | 3 | 4 | −2 | 1 | 2 | ||
| 6 | 4 | 1 | 0 | 0 | 3 | 5 | −1 | 4 | 0 | 3 | 2 | ||
| 12 | 9 | – | 16 | 15 | 16 | 8 | 14 | – | 15 | 16 | – | ||
| 10 | 10 | 11 | 6 | 6 | 5 | 7 | 11 | 6 | 6 | 5 | 1 | ||
| 5 | 6 | 3 | 10 | 10 | 5 | 4 | −5 | −1 | 10 | 5 | 2 | ||
| 2 | −1 | – | 16 | 18 | 17 | −7 | −6 | – | 18 | 17 | – | ||
| −2 | −3 | – | 0 | 4 | −2 | −6 | 0 | – | 4 | −2 | – | ||
| 1 | – | – | 3 | 1 | – | 3 | – | – | 1 | – | – | ||
| 6 | – | – | 3 | 1 | – | 3 | – | – | 1 | – | – | ||
| 19 | 17 | – | 24 | 5 | 3 | 19 | 1 | – | 5 | 3 | – | ||
| 3 | – | 0 | 0 | 5 | 10 | 8 | 11 | 2 | 5 | 10 | 9 | ||
| 0 | 1 | −1 | 0 | 1 | 5 | 0 | −1 | 6 | 1 | 5 | 10 | ||
| −1 | 1 | −6 | −1 | 0 | 2 | −5 | −2 | −10 | 0 | 2 | −2 | ||
| −2 | 0 | – | 2 | 1 | 1 | −4 | 4 | – | 1 | 1 | – | ||
| 15 | 18 | – | 1 | 4 | 1 | 13 | 8 | – | 4 | 1 | – | ||
| 5 | 10 | 9 | 1 | 2 | 0 | 6 | 4 | 9 | 2 | 0 | 0 | ||
| 14 | 8 | 1 | 0 | −2 | 0 | 2 | 5 | −1 | −2 | 0 | 0 | ||
| 1 | – | – | 2 | 4 | – | −1 | – | – | 4 | – | – | ||
| −5 | −5 | −5 | 0 | 2 | 0 | 5 | 4 | −2 | 2 | 0 | −3 | ||
| 5 | 2 | 2 | 1 | 0 | 0 | 8 | 1 | 2 | 0 | 0 | 0 | ||
Notes: 4. Hearts (egocentric). Negative change scores indicate a reduction of egocentric neglect (i.e., more cancellations on the left in T2 relative to T1). 5. Hearts (allocentric). Negative change scores indicate a reduction of allocentric neglect (i.e., fewer errors on the left in T2 relative to T1). T1: time of baseline secondary outcome measure testing, T2: time of post-intervention testing, T3: time of follow-up testing.